JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4062 KW-2478

Target: HSP90

Summary: Potent Hsp90 inhibitor, novel, non-ansamycin,

≥100 mg/mL
A4064 NVP-BEP800

Target: HSP90

Summary: Oral Hsp90β inhibitor, novel, fully synthetic
A4065 PF-04929113 (SNX-5422)

Target: HSP90

Summary: Hsp90 inhibitor,potent and selective

≥23.85 mg/mL
A4071 Fluorouracil (Adrucil)
3 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A2585 MG-132
26 Citation

Target: Proteasome

Summary: Proteasome inhibitor, Cell permeable, reversible

≥23.78 mg/mL
A4049 Marimastat
1 Citation

Target: MMP

Summary: MMPs inhibitor,board spectrum

≥2.8 mg/mL
A4051 NSC 405020
1 Citation

Target: MMP

Summary: MT1-MMP inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4023 LY3039478
1 Citation

Target: Notch

Summary: Notch inhibitor, novel and potent

≥23.2 mg/mL
A1901 Q-VD-OPh
53 Citation

Target: Caspases

Summary: Cell-permeable, irreversible pan-caspase inhibitor

≥25.67 mg/mL
A1903 E 64d
4 Citation

Summary: Cysteine protease inhibitor

insoluble in H2O; ≥17.12 mg/mL